Evidence map›Paper›PMID 32290428›Full record

ReviewBiomolecules2020

New Opportunities for Endometrial Health by Modifying Uterine Microbial Composition: Present or Future?

Nerea M Molina, Alberto Sola-Leyva, Maria Jose Saez-Lara, Julio Plaza-Diaz, Aleksandra Tubić-Pavlović, Barbara Romero, Ana Clavero, Juan Mozas-Moreno, Juan Fontes, Signe Altmäe

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 3 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 3 syntheses or guidelines pooled it, 174 citations in OpenAlex.

  1. Pooled it
  2. Chronic Endometritis and Endometriosis: Two Sides of the Same Coin?Reproductive sciences (Thousand Oaks, Calif.) · 2025
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Nerea M MolinaDepartment of Biochemistry and Molecular Biology, Faculty of Sciences, University of Granada, 18071 Granada, Spain.ORCID 0000-0003-0536-1094
Alberto Sola-LeyvaDepartment of Biochemistry and Molecular Biology, Faculty of Sciences, University of Granada, 18071 Granada, Spain.ORCID 0000-0003-1388-1532
Maria Jose Saez-LaraDepartment of Biochemistry and Molecular Biology, Faculty of Sciences, University of Granada, 18071 Granada, Spain.ORCID 0000-0001-7439-9817
Julio Plaza-DiazInstituto de Investigación Biosanitaria ibs.GRANADA, 18014 Granada, Spain.ORCID 0000-0002-5171-9408
Aleksandra Tubić-PavlovićClinic of Gynecology and Obstetrics, Clinical Center Niš, 18000 Niš, Serbia.
Barbara RomeroInstituto de Investigación Biosanitaria ibs.GRANADA, 18014 Granada, Spain.
Ana ClaveroInstituto de Investigación Biosanitaria ibs.GRANADA, 18014 Granada, Spain.
Juan Mozas-MorenoInstituto de Investigación Biosanitaria ibs.GRANADA, 18014 Granada, Spain.ORCID 0000-0001-6280-9153
Juan FontesInstituto de Investigación Biosanitaria ibs.GRANADA, 18014 Granada, Spain.
Signe AltmäeDepartment of Biochemistry and Molecular Biology, Faculty of Sciences, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-0708-1865
Universidad de Granada · ESInstituto de Investigación Biosanitaria de Granada · ESUniversity of Nis · RS

Funding

European Regional Development Fund B-CTS-500-UGR18Ministerio de Ciencia, Innovación y Universidades PRE2018-0854409Ministerio de Economía, Industria y Competitividad, Gobierno de España RYC-2016-21199Ministerio de Economía, Industria y Competitividad, Gobierno de España SAF2017-87526University of Granada Plan Propio de Investigación 2016 - Excellence actions: Unit of Excellence on Exercise and Health (UCEES) - and Plan Propio de Investigación 2018 - Programa Contratos-Puente, and the Junta de Andalucía, Consejería de Conocimiento, In SOMM17/6107/UGR
6 · The paper itself

Abstract

Current knowledge suggests that the uterus harbours its own microbiota, where the microbes could influence the uterine functions in health and disease; however, the core uterine microbial composition and the host-microbial relationships remain to be fully elucidated. Different studies are indicating, based on next-generation sequencing techniques, that microbial dysbiosis could be associated with several gynaecological disorders, such as endometriosis, chronic endometritis, dysfunctional menstrual bleeding, endometrial cancer, and infertility. Treatments using antibiotics and probiotics and/or prebiotics for endometrial microbial dysbiosis are being applied. Nevertheless there is no unified protocol for assessing the endometrial dysbiosis and no optimal treatment protocol for the established dysbiosis. With this review we outline the microbes (mostly bacteria) identified in the endometrial microbiome studies, the current treatments offered for bacterial dysbiosis in the clinical setting, and the future possibilities such as pro- and prebiotics and microbial transplants for modifying uterine microbial composition.

Indexed as

DiseaseEndometriumFemaleHumansMicrobiotaUterine DiseasesUterusantibioticschronic endometritisendometriosisendometriummicrobiomemicrobiotaprebioticsprobioticsuterus

Identifiers

PMID32290428
PMCPMC7226034
OpenAlexW3015251032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.